Martin Čaprnda (M Caprnda)

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Ejection Fraction

Respiratory Syndrome Coronavirus

Ankylosing Spondylitis

Intensive Care Unit

Top Venues

Infectious disease reports

Stem cells international

This page only lists publications with an associated author ORCID identifier.

Publications

Ján Jurenka, Anna Nagyová, Mohammad Dababseh, Peter Mihalov, Igor Stankovič, Vladimír Boža, Marián Kravec, Michal Palkovič, Martin Čaprnda, Peter Sabaka
Anti-SARS-CoV-2 Antibody Status at the Time of Hospital Admission and the Prognosis of Patients with COVID-19: A Prospective Observational Study. Infectious disease reports 14 (6) (2022)
Ján Jurenka, Anna Nagyová, Mohammad Dababseh, Peter Mihalov, Igor Stankovič, Vladimír Boža, Marián Kravec, Michal Palkovič, Martin Čaprnda, Peter Sabaka
Anti-SARS-CoV-2 Antibody Status at the Time of Hospital Admission and the Prognosis of Patients with COVID-19: A Prospective Observational Study. Infectious disease reports 14 (6) (2022)
Ján Jurenka, Anna Nagyová, Mohammad Dababseh, Peter Mihalov, Igor Stankovič, Vladimír Boža, Marián Kravec, Michal Palkovič, Martin Čaprnda, Peter Sabaka
Anti-SARS-CoV-2 Antibody Status at the Time of Hospital Admission and the Prognosis of Patients with COVID-19: A Prospective Observational Study. Infectious disease reports 14 (6) (2022)
Eleonora Russo, Martin Čaprnda, Peter Kruzliak, Pier Giulio Conaldi, Cesario Venturina Borlongan, Giampiero La Rocca
Umbilical Cord Mesenchymal Stromal Cells for Cartilage Regeneration Applications. Stem cells international 2022 (2022)